Study to evaluate the efficacy of 5 weeks and 6 weeks intervals tocilizumab infusion in active rheumatoid arthritis patients.
Phase of Trial: Phase IV
Latest Information Update: 11 Nov 2015
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate; Prednisolone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms SIWETO
- 29 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.